Friday, December 10, 2004 12:21:35 PM
Perhaps the positive results to date w/ Abraxane's nanoparticle formulation has spurred optimism about the new Panzem NCD formulation (NanoCrystal Dispersion).
As per Cycle Dude:
nanotech success...11.8.04 http://abclocal.go.com/wtvd/health/110804_NH_breastcancerdrug.html
Abraxane is given intravenously on a weekly basis. Unlike other cancer drugs, namely Taxol and Taxotere, Abraxane does not contain toxic substances. Instead, using a special technology, Abraxane contains the drug taxane paclitaxel with the body's natural transport protein called albumin. These are made into tiny tiny particles, a nanoparticle, which are 1/100th the size of a red blood cell. These nanoparticles get into the vessels rapidly carrying more drug to the tumor more quickly, and less drug indiscriminately to normal, healthy cells.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM